United States · What does Avoro Capital Advi... invest in?
Avoro Capital Advi... says it invests in Life Science, Gene Therapy and Psychedelics.
What they do
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- Series ASeries BGrowth
- Sectors
- Life ScienceGene TherapyPsychedelics
- Based in
- United States
- Cold pitches
- Not stated
The record
No rounds observed yet. That is a limit of the sources we read, not a finding about the firm. If it has invested, a round will put it here. Know a round it was in? Tell us.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
BABehzad AghazadehManaging DirectoriForm ADV
NCNeil CammarosanoChief Financial OfficeriForm ADV
SAScott Andrew EpsteinChief Operating Officer and Chief Compliance OfficeriForm ADV
We also hold 14 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$14Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Avoro Capital Advisors LLC
- SEC number
- CRD 154091
Funds on its Form ADV
2 private funds, $8.7B in gross assets · filed Jun 2024
Hedge 1Venture 1
- Avoro Life Sciences Fund LLCHedge405 investors$8.6B
- Avoro Ventures Fund L.P.Venture48 investors$166M
What they claim to have backed
From their own portfolio page (on their website)
25 of 52 we have independently watched raise
Acerta PharmaAdaptimmuneAllogene TherapeuticsAmarinApellis PharmaceuticalsAvidityConstellation PharmaceuticalsEthyreal BioHemabHorizon TherapeuticsKaryopharm TherapeuticsKrystal BiotechKura OncologyMerusOttimo PharmaOutlook TherapeuticsPMV PharmaceuticalsTricida (TCDA)Trillium TherapeuticsVanqua BioViceBioViking TherapeuticsVividionXenon PharmaceuticalsZealand PharmaAdverum BiotechnologoesAerie Pharmaceuticals (AERI)Ascendis (ASND)Assembly Biosciences (ASMB)Avadel PharmaceuticalsBellicumCatalyst Biosciences (CBIO)Corvus Pharmaceuticals (CRVS)CymabayDiceFennec Pharmaceuticals (FENC)IO Biotech ApSIntec Pharmaceuticals (NTEC)Investor PortalIovance Biotherapeutics (IOVA)IvericMadrigalMarinuspharmaMirati TherapeuticsOlema PharmaceuticalsPraxis Precision MedicinesProteostasis Therapeutics Inc. (PTI)Rocket PharmaceuticalsSarepta Therapeutics (SRPT)Stemline Therapeutics (STML)TourmalineViveve Medical (VIVE)
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.